Hsa-MiR-590-3p Promotes the Malignancy Progression of Pancreatic Ductal Carcinoma by Inhibiting the Expression of p27 and PPP2R2A via G1/S Cell Cycle Pathway

Hsa-MiR-590-3p Promotes the Malignancy Progression of Pancreatic Ductal Carcinoma by Inhibiting the Expression of p27 and PPP2R2A via G1/S Cell Cycle Pathway

Xiaoyang Shi, Weiwei Sheng, Chao Jia, Jingtong Tang, Ming Dong Department of General Surgery, Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang 110001, People’s Republic of ChinaCorrespondence: Ming Dong Email dongming@cmu.edu.cnObjective: To investigate the...

Full description

Bibliographic Details
Main Authors: Shi X, Sheng W, Jia C, Tang J, Dong M
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:OncoTargets and Therapy
Subjects:
mir-590-3p
pancreatic ductal carcinoma
p27
ppp2r2a
g1/s cell cycle pathway；
Online Access:https://www.dovepress.com/hsa-mir-590-3p-promotes-the-malignancy-progression-of-pancreatic-ducta-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/hsa-mir-590-3p-promotes-the-malignancy-progression-of-pancreatic-ducta-peer-reviewed-article-OTT

Similar Items